I-Mab Biopharma Investors

21 investors on Angel Roster list I-Mab Biopharma in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Series A and the largest groups are based in the United States, China and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name I-Mab Biopharma can appear together.

Investors listed
21
With verified email
38%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 I-Mab Biopharma investors

The most complete profiles first. Showing 21 of 21.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • Bing YuanVerified

    Private Equity Firm · China

    Health CareRemote Work TechE-commerceDesign

    Portfolio: The We Company, Vuclip, Mr&Mrs Italy, Sundan and 28 more

    Contact details available

  • Eric ChenVerified

    Private Equity Firm · China

    Health CareRemote Work TechE-commerceDesign

    Portfolio: The We Company, Vuclip, Mr&Mrs Italy, Sundan and 28 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Yan HuangVerified

    Private Equity Firm · China

    Health CareE-commerceCustomer ServiceConsumer Goods

    Portfolio: Babycare, SITECH DEV, Yunji Technology, MXB Biotechnologies and 80 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • John Zhao

    Private Equity Firm · China

    Health CareRemote Work TechE-commerceDesign

    Portfolio: The We Company, Vuclip, Mr&Mrs Italy, Sundan and 28 more

    Contact details available

  • Owen Guo

    Private Equity Firm · China

    Health CareRemote Work TechE-commerceDesign

    Portfolio: The We Company, Vuclip, Mr&Mrs Italy, Sundan and 28 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Wei Ying

    Private Equity Firm · Hong Kong

    Health CareE-commerceCustomer ServiceConsumer Goods

    Portfolio: Babycare, SITECH DEV, Yunji Technology, MXB Biotechnologies and 80 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many I-Mab Biopharma investors are on Angel Roster?

Angel Roster lists 21 I-Mab Biopharma investors. 8 of them (38%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (21) and Venture Capital Firms (10). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do I-Mab Biopharma investors invest in?

Among those that list a stage, the most common are Series A (5) and Seed (5).

Where are I-Mab Biopharma investors based?

Most are based in the United States (7), China (6) and Hong Kong (3).

Which companies have I-Mab Biopharma investors backed?

The most-backed portfolio companies among them are Nuvation Bio (15), Chinook Therapeutics (15), UNUM Therapeutics (15), Syros Pharmaceuticals (15) and Harbour Biomed (12).

How do I contact I-Mab Biopharma investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.